Leerink Partners Downgrades Equillium to Market Perform, Lowers Price Target to $1
Benzinga Newsdesk 1 year ago
NewsDowngradesPrice TargetAnalyst Ratings
Leerink Partners analyst Thomas Smith downgrades Equillium (NASDAQ:EQ) from Outperform to Market Perform and lowers the price target from $3 to $1.
Leerink Partners analyst Thomas Smith downgrades Equillium (NASDAQ:EQ) from Outperform to Market Perform and lowers the price target from $3 to $1.